Resources | Article

February 16, 2022

A Novel, High-Throughput Platform to Characterize Novel IBD Therapeutics

RepliGut Planar Model provides a model to study TNF-a inflammation in the gut and conduct high-throughput screening of IBD therapeutics.

December 23, 2020

How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?

Altis Biosystems offers human intestinal models that accurately translate results from preclinical experiments to late-stage clinical trials.